Navigation Links
Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohn's Disease and Ulcerative Colitis in the United States
Date:6/21/2013

Inc. and Takeda Global Research & Development Center, Inc.
Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology, and cardiovascular treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for metabolic and cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.takeda.us.

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
2. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
3. Takeda to Acquire Inviragen, Inc.
4. Takeda Responds to Verdict in Diabetes Drug Case
5. Takeda Launches New Subsidiary in Ecuador
6. Takeda lanza nueva subsidiaria en Ecuador
7. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
8. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
11. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 The Canadian Society for ... specific tests, treatments or procedures that are commonly ... as part of Choosing Wisely Canada.  The list ... support conversations between patients and physicians about what ... Society for Vascular Surgery,s list identified the following ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5tzcx6/specialty_enzymes ) has ... Global Strategic Business Report" report to their offering. ... following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and ... US, Canada , Japan ... Asia-Pacific , Latin America , ...
(Date:6/2/2015)... PITTSBURGH , June 2, 2015 ... technology (HIT) consulting firm, today announced the celebration ... organizations served throughout the U.S., since its inception ... for a skillful workforce in the healthcare technology ... resources with a company-wide dedication to facilitating clients, ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... March 7, 2012   Leading events organiser UBM ... announced that CPhI Japan will return to its traditional March ... held on a smaller scale in Osaka, Japan to accommodate ... to stabilize, Tokyo will once again play host to CPhI ...
... 7, 2012  ThermoGenesis Corp. (NASDAQ: KOOL ) a ... store adult stem cells, said today that it will be ... Stock Conference on Wednesday, March 14. The presentation ... begin at 10:30 a.m., Pacific Daylight Time (1:30 p.m., Eastern ...
Cached Medicine Technology:CPhI Japan Returns to Tokyo for 2012 2CPhI Japan Returns to Tokyo for 2012 3
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, Brian Smith, drove ... 207.9 mph. In the process, Hennessey’s potent pony car ... mark. Jay Leno was on hand to witness the ... Garage, which will air on CNBC later this year. , ... oval at the Continental Tire Proving Grounds located in Uvalde, ...
(Date:6/2/2015)... UCLA Health and Exer have completed ... and expand urgent care services in Los Angeles County. ... University of California Board of Regents and the Exer ... Health to purchase a minority share of four existing ... Park and Northridge and creates opportunity to grow and ...
(Date:6/2/2015)... 02, 2015 TMG Health, the leading ... plans in the Medicare Advantage, Medicare Part D, and ... and exhibitor at AHIP’s Institute 2015, the annual meeting ... The conference will be held June 3-5 in Nashville, ... offer opportunities for attendees to schedule private discussions with ...
(Date:6/2/2015)... 02, 2015 On October 1, 2015 ... for another delay. , On Monday, June 1st ... for the House Ways and Means Committee, and 12 ... for Medicare and Medicaid Services, urging the administration to ... rolls out ICD-10. ICD-10 is the newest coding system ...
(Date:6/2/2015)... Los Angeles, California (PRWEB) June 02, 2015 ... packaging, sealers and sorbent systems, has announced the ... combat accidental ingestion of poisons by children, especially ... to ASTM D3475 standards and tested to CFR ... President/Technical Director Kevin Cullen. , Looks Like Candy, ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... Nov. 5 One of Fayette,County,s largest employers will ... help of an $8.4 million, 20-year investment by the ... each year through the,Fayette County Redevelopment Authority, on behalf ... The funds will be used to jump start ...
... eye care facility in Tanzania to,be honored with ... Nov. 5 Today, Seva,Foundation proudly honors the ... preventable blindness around the world -- Dr. Paul,Courtright ... Center for Community Ophthalmology (KCCO),which Courtright and Lewallen ...
... published in the journal of Minerva Cardioangiologica reveals Pycnogenol, ... reduces jetlag in passengers by nearly 50 percent. The ... a scoring system, showed Pycnogenol lowered symptoms of jetlag ... in both healthy individuals and hypertensive patients. Passengers also ...
... Nov. 5 Americans United for Life,(AUL) today ... initiatives. The election saw pro-life ballot initiatives on,abortion ... legalizing physician-assisted suicide in Washington state and,destructive embryonic ... Dr. Charmaine Yoest, President & CEO of AUL ...
... physicians look forward to health system reform in 2009, ... by Nancy Nielsen, M.D., AMA President:, "The American ... for the presidency of the United States. He has,proposed ... and made it a,central issue in his campaign., ...
... 5 Dynamics Research,Corporation (Nasdaq: DRCO ... engineering, technology and information technology services and,solutions ... that it,received an $11.4 million task order ... (TEAMS) indefinite delivery and indefinite,quantity (ID/IQ) contract, ...
Cached Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 3Health News:Study shows pine bark reduces jetlag 2Health News:Study shows pine bark reduces jetlag 3Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 2Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 3Health News:AMA Congratulates President-Elect Obama 2Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 2Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 3
Standard 20x long working distance objectives for greater magnifications of your microtools....
... An economical laboratory tissue culture microscope, the ... expand their applications. Olympus has taken the ... CKX41. Fluorescence can be used with an ... can be carried out on the CKX41 ...
... Eclipse TE2000S is an advanced ... research. It's exclusive CFI60 optical ... high numerical aperatures and longer ... inverted microscope to take full ...
... new Eclipse TS-100 is an innovative ... high quality tool complements any research ... CFI60 optics offer brilliant, sharp ... superb optical performance with high resolution ...
Medicine Products: